Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

• Jean-Yves Blay,
• Antoine Italiano,
• Axel Le Cesne,
• Olivier Mir,
• Davide Bedognetti,
• Michele Ceccarelli,
• Pascal Finetti,
• Daniel Birnbaum,
• Francois Bertucci,
• Emilie Mamessier,
• Vincent Niziers,
• Alexandre de Nonneville,
• Léna Mescam

Affiliations

Jean-Yves Blay

Medical Oncology, Centre Léon Bérard, Lyon, Rhône-Alpes, France

Antoine Italiano

10 Department of Medical Oncology, Institute Bergonie, Bordeaux, Aquitaine, France

Axel Le Cesne

11 Medical Oncology Department, Institut Gustave Roussy, Villejuif, France

Olivier Mir

2 Department of Ambulatory Care, University Paris Saclay, Villejuif, France

Davide Bedognetti

Cancer Research Department, Sidra Medicine, Doha, Qatar

Michele Ceccarelli

Aff1 grid.466961.aQatar Computing Research Institute Doha Qatar

Pascal Finetti

Aff5 grid.418443.e0000000405984440Department of Molecular OncologyInstitut Paoli-Calmettes U1068 Inserm Marseille France

Daniel Birnbaum

Aff5 grid.418443.e0000000405984440Department of Molecular OncologyInstitut Paoli-Calmettes U1068 Inserm Marseille France

Francois Bertucci

Aff5 grid.418443.e0000000405984440Department of Molecular OncologyInstitut Paoli-Calmettes U1068 Inserm Marseille France

Emilie Mamessier

Radiation Oncology/Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Boston, Massachusetts, USA

Vincent Niziers

Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France

Alexandre de Nonneville

Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France

Léna Mescam

French Sarcoma Group, Lyon, France